Literature DB >> 19357956

Surgical management of craniopharyngiomas.

Ricardo J Komotar1, Marie Roguski, Jeffrey N Bruce.   

Abstract

Surgical treatment of craniopharyngiomas has been historically challenging and, despite advancements in microsurgical and skull base techniques, continues to pose a challenge to modern day surgeons. In particular, proponents of subtotal resection in conjunction with radiotherapy argue that this less aggressive approach can yield equivalent control rates with lower morbidity, while others argue that gross total resection is superior. Regardless of whether gross total or subtotal resection is the goal, surgical planning must include a thorough endocrine and neuro-ophthalmologic evaluation as well as imaging, and the approach, whether transsphenoidal or transcranial, must take into account the nature of the tumor and its location. In addition, optimal management of craniopharyngiomas must consist of an individualized and multidisciplinary approach not only including neurological surgery, but also including endocrinology, neuro-ophthalmology, neuropsychology, and, often, radiation-oncology.

Entities:  

Mesh:

Year:  2009        PMID: 19357956     DOI: 10.1007/s11060-009-9841-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  58 in total

Review 1.  Modifications to the orbitozygomatic approach. Technical note.

Authors:  G Michael Lemole; Jeffrey S Henn; Joseph M Zabramski; Robert F Spetzler
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

2.  Endoscopic cranial base surgery: classification of operative approaches.

Authors:  Theodore H Schwartz; Justin F Fraser; Seth Brown; Abtin Tabaee; Ashutosh Kacker; Vijay K Anand
Journal:  Neurosurgery       Date:  2008-05       Impact factor: 4.654

3.  Craniopharyngiomas in children and adults.

Authors:  J T Hoff; R H Patterson
Journal:  J Neurosurg       Date:  1972-03       Impact factor: 5.115

4.  Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.

Authors:  C J de Vile; D B Grant; R D Hayward; B E Kendall; B G Neville; R Stanhope
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

Review 5.  Postradiation astrocytoma. Report of two cases.

Authors:  C Kitanaka; N Shitara; T Nakagomi; H Nakamura; S Genka; K Nakagawa; A Akanuma; H Aoyama; K Takakura
Journal:  J Neurosurg       Date:  1989-03       Impact factor: 5.115

6.  Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources.

Authors:  J Voges; V Sturm; R Lehrke; H Treuer; C Gauss; F Berthold
Journal:  Neurosurgery       Date:  1997-02       Impact factor: 4.654

7.  Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.

Authors:  M G Yaşargil; M Curcic; M Kis; G Siegenthaler; P J Teddy; P Roth
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

Review 8.  Craniopharyngioma in children.

Authors:  R A Sanford; M S Muhlbauer
Journal:  Neurol Clin       Date:  1991-05       Impact factor: 3.806

9.  Transpetrosal-transtentorial approach and its application in the therapy of retrochiasmatic craniopharyngiomas.

Authors:  A Hakuba; S Nishimura; Y Inoue
Journal:  Surg Neurol       Date:  1985-10

10.  Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients.

Authors:  Elfar Ulfarsson; Christer Lindquist; Maud Roberts; Tit Rähn; Melker Lindquist; Marja Thorén; Bodo Lippitz
Journal:  J Neurosurg       Date:  2002-12       Impact factor: 5.115

View more
  18 in total

1.  Transient obscuration of vision.

Authors:  Robert Corns; Lamia Nayeb; Andrew Martin
Journal:  BMJ Case Rep       Date:  2012-08-18

2.  Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.

Authors:  Brad E Zacharia; Samuel S Bruce; Hannah Goldstein; Hani R Malone; Alfred I Neugut; Jeffrey N Bruce
Journal:  Neuro Oncol       Date:  2012-06-26       Impact factor: 12.300

3.  Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma.

Authors:  Hiromitsu Iwata; Koshi Tatewaki; Mitsuhiro Inoue; Naoki Yokota; Yoshimi Baba; Ryutaro Nomura; Yuta Shibamoto; Kengo Sato
Journal:  J Neurooncol       Date:  2011-08-23       Impact factor: 4.130

4.  Co-localisation of meningioma and craniopharyngioma mimicking a single skull base tumour in an elderly patient.

Authors:  Alessandro Della Puppa; Giulia Del Moro; Luigino Tosatto; Renzo Manara; Enrico Orvieto; Marina Paola Gardiman; Renato Scienza
Journal:  J Neurooncol       Date:  2010-07-09       Impact factor: 4.130

5.  Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cystic craniopharyngiomas in 53 patients.

Authors:  Philipp Kickingereder; Mohammad Maarouf; Faycal El Majdoub; Manuel Fuetsch; Ralph Lehrke; Jochen Wirths; Klaus Luyken; Klaus Schomaecker; Harald Treuer; Juergen Voges; Volker Sturm
Journal:  J Neurooncol       Date:  2012-06-21       Impact factor: 4.130

6.  Outcomes of Gamma Knife surgery for craniopharyngiomas.

Authors:  Zhiyuan Xu; Chun-Po Yen; David Schlesinger; Jason Sheehan
Journal:  J Neurooncol       Date:  2010-12-14       Impact factor: 4.130

7.  Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation.

Authors:  Zheng Shi; Natia Esiashvili; Anna J Janss; Claire M Mazewski; Tobey J MacDonald; David M Wrubel; Barunashish Brahma; Frederick P Schwaibold; Robert B Marcus; Ian R Crocker; Hui-Kuo G Shu
Journal:  J Neurooncol       Date:  2012-06-13       Impact factor: 4.130

Review 8.  Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance.

Authors:  Saira Alli; Semra Isik; James T Rutka
Journal:  J Neurooncol       Date:  2016-05-19       Impact factor: 4.130

9.  Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma.

Authors:  Todd C Hankinson; Emma C Fields; Michelle R Torok; Brenda L Beaty; Michael H Handler; Nicholas K Foreman; Brent R O'neill; Arthur K Liu
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

10.  Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.

Authors:  Stewart Goldman; Ian F Pollack; Regina I Jakacki; Catherine A Billups; Tina Y Poussaint; Adekunle M Adesina; Ashok Panigrahy; Donald W Parsons; Alberto Broniscer; Giles W Robinson; Nathan J Robison; Sonia Partap; Lindsay B Kilburn; Arzu Onar-Thomas; Ira J Dunkel; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.